Site name unknown, Glasgow G12 0YH

Site:	Site name unknown, Glasgow G12 0YH
Address:
City:	Glasgow
State:
Zip:	G12 0YH
Country:	UK

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors (Resistant at 400 mg Imatinib)	Terminated	Closed	Sunitinib or Imatinib	NCT00372567